Evidence map›Paper›PMID 23190643›Full record

ReviewGenes and immunity2013

Dual-specificity phosphatases 2: surprising positive effect at the molecular level and a potential biomarker of diseases.

W Wei, Y Jiao, A Postlethwaite, J M Stuart, Y Wang, D Sun, W Gu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Genes and immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Protein phosphatases in systemic autoimmunity.Immunometabolism (Cobham, Surrey) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

W WeiInstitute of Endemic Fluorosis Disease, Center for Endemic Disease Control, Center for Disease Control and Prevention, Harbin Medical University, Harbin, PRC.
Y Jiao
A Postlethwaite
J M Stuart
Y Wang
D Sun
W Gu
University of Tennessee Health Science Center · USBeijing Tian Tan Hospital · CNCampbell Clinic · USCenter for Disease Control · TWHarbin Medical University · CN

Funding

Study gene for alcoholism using mouse modelsR01AA016342 · NIAAA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI GU, WEIKUAN · 2009 to 2010
$666k
NIAAA NIH HHS 1R01 AA016342
6 · The paper itself

Abstract

Dual-specificity phosphatases (DUSPs) is an emerging subclass of the protein tyrosine phosphatase gene superfamily, a heterogeneous group of protein phosphatases that can dephosphorylate both phosphotyrosine and phosphoserine/phosphothreonine residues within the one substrate. Recently, a series of investigations of DUSPs defined their essential roles in cell proliferation, cancer and the immune response. This review will focus on DUSP2, its involvement in different diseases and its potential as a therapeutic target.

Indexed as

Adaptive ImmunityAnimalsBiomarkersDual Specificity Phosphatase 2HumansInfectionsInflammationMAP Kinase Signaling SystemNeoplasmsBiomarkersDual Specificity Phosphatase 2

Identifiers

PMID23190643
OpenAlexW2034598412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.